Skip to content
Clinical Trials – home

Centre Hospitalier Universitaire De Nice

Research site

France 10 Rue Moliere, 06100 Nice, France

  • 1 trial recruiting
  • Dementia Alzheimer's type
  • Adult patients

About Specializations

Centre Hospitalier Universitaire De Nice in Nice, France specialises in clinical trials of conditions such as Dementia Alzheimer's type, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases

The geriatric unit at Centre Hospitalier Universitaire De Nice is conducting research focused on neurodegenerative conditions, primarily Alzheimer's disease. Trials aim to assess safety and efficacy of novel agents to slow cognitive decline.

  • Evaluation of safety profiles for new compounds
  • Measurement of cognitive outcomes using standardized scales
  • Improvement of daily functioning in mild to moderate stages

These studies support the development of therapies that could preserve memory and independence for older adults.

Mental Disorders

Within the same department, investigators explore mental disorders linked to dementia, testing whether combined treatments such as KarXT can enhance thinking abilities and overall functioning in patients with mild to moderate Alzheimer’s.

  • Assessment of global cognitive performance
  • Monitoring of adverse events for tolerability
  • Exploration of synergistic drug combinations

The goal is to identify strategies that improve quality of life for individuals facing both neurological and psychiatric challenges.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
10 Rue Moliere06100 NiceFrance
Recruiting now
1 trial
Conditions studied
1

More sites in NiceFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dementia Alzheimer's type

Not yet recruiting

Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
  • Sponsor:Prinnovation GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.